Takayuki Hishiki Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

1/2016

Generation of a neutralization-resistant CCR5 tropic simian/human immunodeficiency virus (SHIV-MK38) molecular clone, a derivative of SHIV-89.6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Hishiki Research Topics

Disease

17	Infections 01/2024 - 11/2010
3	COVID-19 10/2023 - 01/2022
3	Dengue (Dengue Fever) 12/2019 - 01/2016
2	Smallpox (Variola) 01/2023 - 01/2023
2	Hepatitis C 11/2018 - 09/2018
2	Virus Diseases (Viral Diseases) 11/2018 - 05/2015
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2024
1	Thrombosis (Thrombus) 10/2023
1	Inflammation (Inflammations) 10/2023
1	Critical Illness (Critically Ill) 10/2023
1	Zoonoses 01/2023
1	Severe Acute Respiratory Syndrome 09/2020
1	Hepatitis A (Hepatitis, Infectious) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Fatty Liver 07/2011
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2011
1	Hepatocellular Carcinoma (Hepatoma) 07/2011
1	Liver Diseases (Liver Disease) 07/2011
1	Chronic Hepatitis C 07/2011
1	T-Cell Leukemia (Leukemia, T Cell) 09/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2007

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 12/2022 - 05/2014
6	VaccinesIBA 12/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2007
3	LuciferasesIBA 12/2022 - 01/2014
2	InterferonsIBA 01/2024 - 01/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 09/2020
2	tecovirimatIBA 01/2023 - 01/2023
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023 - 01/2023
2	brincidofovirIBA 01/2023 - 01/2023
1	Interferon Type IIBA 01/2024
1	Small Interfering RNA (siRNA)IBA 01/2024
1	Ubiquitin-Specific ProteasesIBA 01/2024
1	Monoclonal AntibodiesIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	Complement Factor B (Factor B)IBA 10/2023
1	Complement Factor D (Factor D)IBA 10/2023
1	ProteomeIBA 10/2023
1	Gemcitabine FDA Link 01/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2023
1	R 121919IBA 12/2022
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 12/2022
1	N- (1- ethylpropyl)- (3- methoxy- 5- (2- methoxy- 4- trifluoromethoxyphenyl)- 6- methyl- pyrazin- 2- yl)amineIBA 12/2022
1	Subgenomic RNAIBA 12/2022
1	CP 154526IBA 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	EnzymesIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	PolyphenolsIBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2022
1	TeaIBA 01/2022
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 09/2020
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2018
1	Antimalarials (Antimalarial Agents)IBA 09/2018
1	hirsutineIBA 01/2017
1	Apolipoproteins B (ApoB)IBA 10/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2014
1	YYA-021IBA 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 12/2013
1	Viral RNAIBA 12/2013
1	A-factor (Streptomyces)IBA 07/2011
1	Lipoproteins (Lipoprotein)IBA 07/2011
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 11/2010
1	Lipase (Acid Lipase)FDA Link 11/2010
1	tax Gene Products (tax Gene Product)IBA 09/2007
1	Cyclic AMP (AMP, Cyclic)IBA 09/2007
1	ElementsIBA 09/2007
1	Carrier Proteins (Binding Protein)IBA 09/2007